VIPR1-AS1: A Potential Drug Target and Biomarker (G100874007)
VIPR1-AS1: A Potential Drug Target and Biomarker
Virtual screening and virtual validation are becoming increasingly important in the drug development process. These techniques allow researchers to identify potential drug targets and biomarkers, which can significantly reduce the number of drugs that need to be screened and tested. One potential drug target and biomarker that has gained attention in recent years is VIPR1-AS1.
VIPR1-AS1 is a gene that is expressed in many tissues and organs, including the brain, heart, and lungs. It is a member of the VIPR gene family, which is known for its role in cell signaling pathways. The VIPR1-AS1 gene has been shown to play a role in the regulation of cell proliferation and survival, and it has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and respiratory diseases.
As a potential drug target, VIPR1-AS1 has the potential to be used to treat a wide range of diseases. For example, VIPR1-AS1 has been shown to be involved in the regulation of cell proliferation and has been linked to the development of cancer. Therefore, it is potential to be used as a target for anti-cancer drugs. Additionally, VIPR1-AS1 has also been shown to be involved in the regulation of cell survival and has been linked to the development of neurodegenerative diseases. Therefore, it has potential as a target for drugs that target these conditions.
As a biomarker, VIPR1-AS1 has the potential to be used as a diagnostic tool for a wide range of diseases. For example, VIPR1-AS1 has been shown to be expressed in many tissues and organs, including the brain, heart, and lungs, which makes it a potential biomarker for a wide range of diseases. Additionally, VIPR1-AS1 has been shown to play a role in the regulation of cell signaling pathways, which makes it a potential biomarker for diseases that are characterized by changes in cell signaling.
In conclusion, VIPR1-AS1 is a gene that has the potential to be a drug target and biomarker. Further research is needed to fully understand its role in disease and to develop safe and effective drugs that target it.
Protein Name: VIPR1 Antisense RNA 1
More Common Targets
VIPR2 | VIRMA | VIT | VKORC1 | VKORC1L1 | VLDLR | VLDLR-AS1 | VMA21 | VMAC | VMO1 | VMP1 | VN1R1 | VN1R101P | VN1R108P | VN1R10P | VN1R11P | VN1R12P | VN1R17P | VN1R18P | VN1R2 | VN1R4 | VN1R46P | VN1R5 | VN1R82P | VN1R91P | VN1R96P | VN2R11P | VN2R1P | VN2R3P | VNN1 | VNN2 | VNN3P | Voltage-dependent anion channels (Porins) | Voltage-dependent calcium channel gamma subunit | Voltage-gated K(v) channel | Voltage-Gated Sodium Channel Complex | Volume-Regulated Anion Channel (VRAC) | VOPP1 | VOR Complex | VPREB1 | VPREB3 | VPS11 | VPS13A | VPS13A-AS1 | VPS13B | VPS13C | VPS13C-DT | VPS13D | VPS16 | VPS18 | VPS25 | VPS26A | VPS26AP1 | VPS26B | VPS26C | VPS28 | VPS29 | VPS33A | VPS33B | VPS35 | VPS35L | VPS36 | VPS37A | VPS37B | VPS37C | VPS37D | VPS39 | VPS41 | VPS45 | VPS4A | VPS4B | VPS50 | VPS51 | VPS51P8 | VPS52 | VPS53 | VPS54 | VPS72 | VPS8 | VPS9D1 | VPS9D1-AS1 | VRK1 | VRK2 | VRK3 | VRTN | VSIG1 | VSIG10 | VSIG10L | VSIG10L2 | VSIG2 | VSIG4 | VSIG8 | VSIR | VSNL1 | VSTM1 | VSTM2A | VSTM2A-OT1 | VSTM2B | VSTM2B-DT | VSTM2L